KURA FY 2014 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$802M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$23,907

Operating Income

-$12M

Net Income

-$11M

EPS (Diluted)

$-2.69

Cash Flow

Operating Cash Flow

-$2,547

Free Cash Flow

-$2,631

Stock-Based Comp.

$711

Balance Sheet

Total Assets

$1M

Total Liabilities

$5M

Stockholders' Equity

-$3M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$23,907	-$22,734	-5.2%
Operating Income	-$12M	-$22,341	-52726.6%
Net Income	-$11M	-$27,315	-40218.5%